Rémy Beaudouin

Rémy Beaudouin

Auto-generated profile, based on publicly available information

Rémy Beaudouin

Innovative Approaches for Human Health and Environmental Protection Unit (NAHE), INERIS, 65550 Verneuil en Halatte, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Science of The Total Environment
Verified
Journal Article
Closed access
AGAudrey Grech
Audrey Grech
CBCéline Brochot
Céline Brochot
JDJean-Lou Dorne
Jean-Lou Dorne
NQNadia Quignot
Nadia Quignot
FBFrédéric Y. Bois
Frédéric Y. Bois
RBRémy Beaudouin
Rémy Beaudouin

1 November 2018 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
CBClaire Beausoleil
Claire Beausoleil
CEClaude Emond
Claude Emond
JCJean-Pierre Cravedi
Jean-Pierre Cravedi
JAJean-Philippe Antignac
Jean-Philippe Antignac
MAMartine Applanat
Martine Applanat
CMCécile Michel
Cécile Michel

1 February 2019 in Science of The Total Environment
Verified
Journal Article
Closed access
AGAudrey Grech
Audrey Grech
CTCleo Tebby
Cleo Tebby
CBCéline Brochot
Céline Brochot
FBFrédéric Y. Bois
Frédéric Y. Bois
ABAnne Bado-Nilles
Anne Bado-Nilles
RBRémy Beaudouin
Rémy Beaudouin

24 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DEDan Elgrabli
Dan Elgrabli
RBRemy Beaudouin
Remy Beaudouin
NJNawel Jbilou
Nawel Jbilou
MFMagali Floriani
Magali Floriani
APAlexandre Pery
Alexandre Pery
GLGhislaine Lacroix
Ghislaine Lacroix
Titanium dioxide (TiO2) nanoparticles are used in many applications. Due to their small size, easy body penetration and toxicological adverse effects have been suspected. Numerous studies have tried to characterize TiO2 translocation after oral, dermal or respiratory exposure. In this study, we focused on TiO2 nanoparticle biodistribution, clearance and toxicological effects after intravenous injection, considering TiO2 translocation in the blood occurs. Using ICP-OES, transmission electron microscopy, and histological methods, we found TiO2 accumulation in liver, lungs and spleen. We estimated TiO2 nanoparticles’ half life in the body to about 10 days. Clinical biomarkers were also quantified for 56 days to identify potential toxicological impact on lungs, blood, liver, spleen and kidneys. Results showed absence of toxicological effects after TiO2 intravenous injection at concentrations of 7.7 to 9.4 mg/kg.

2 December 2013 in Environmental Science & Technology
Verified
Journal Article
Closed access
APAlexandre R. R. Péry
Alexandre R. R. Péry
JDJames Devillers
James Devillers
CBCéline Brochot
Céline Brochot
EMEnrico Mombelli
Enrico Mombelli
OPOlivier Palluel
Olivier Palluel
RBRémy Beaudouin
Rémy Beaudouin

1 March 2006 in Ecological Modelling
Verified
Journal Article
Closed access
VGVincent Ginot
Vincent Ginot
SGSabrina Gaba
Sabrina Gaba
RBRémy Beaudouin
Rémy Beaudouin
FAFranck Aries
Franck Aries
HMHervé Monod
Hervé Monod